{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T16:26:15Z","timestamp":1792599975720,"version":"4.5.0"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T00:00:00Z","timestamp":1761782400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T00:00:00Z","timestamp":1761782400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pharmacol Toxicol"],"DOI":"10.1186\/s40360-025-01016-9","type":"journal-article","created":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T13:15:51Z","timestamp":1761830151000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Imidacloprid contributes to bladder cancer progression: preliminary evidence based on network toxicology, machine learning and molecular docking"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1194-1810","authenticated-orcid":false,"given":"Jie","family":"Ming","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0352-7583","authenticated-orcid":false,"given":"Song","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1740-8278","authenticated-orcid":false,"given":"Zhanliang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-0762-690X","authenticated-orcid":false,"given":"Kun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5927-5493","authenticated-orcid":false,"given":"Mingjun","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0870-4056","authenticated-orcid":false,"given":"Yinong","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,30]]},"reference":[{"key":"1016_CR1","doi-asserted-by":"publisher","first-page":"17285","DOI":"10.1007\/s11356-017-9240-x","volume":"24","author":"TJ Wood","year":"2017","unstructured":"Wood TJ, Goulson D. The environmental risks of neonicotinoid pesticides: a review of the evidence post 2013. Environ Sci Pollut Res Int. 2017;24:17285\u2013325.","journal-title":"Environ Sci Pollut Res Int"},{"key":"1016_CR2","doi-asserted-by":"publisher","first-page":"51098","DOI":"10.1007\/s11356-024-34571-5","volume":"31","author":"L Liao","year":"2024","unstructured":"Liao L, Sun T, Gao Z, et al. Neonicotinoids as emerging contaminants in China\u2019s environment: a review of current data. Environ Sci Pollut Res Int. 2024;31:51098\u2013113.","journal-title":"Environ Sci Pollut Res Int"},{"key":"1016_CR3","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1093\/ije\/dyv195","volume":"45","author":"S Koutros","year":"2016","unstructured":"Koutros S, Silverman DT, Alavanja MC, et al. Occupational exposure to pesticides and bladder cancer risk. Int J Epidemiol. 2016;45:792\u2013805.","journal-title":"Int J Epidemiol"},{"key":"1016_CR4","doi-asserted-by":"publisher","first-page":"11395","DOI":"10.3390\/ijms241411395","volume":"24","author":"CA Lucchesi","year":"2023","unstructured":"Lucchesi CA, Vasilatis DM, Mantrala S, et al. Pesticides and bladder cancer: mechanisms leading to anti-cancer drug chemoresistance and new chemosensitization strategies. Int J Mol Sci. 2023;24:11395.","journal-title":"Int J Mol Sci"},{"key":"1016_CR5","doi-asserted-by":"publisher","first-page":"108555","DOI":"10.1016\/j.envres.2019.108555","volume":"176","author":"M Ospina","year":"2019","unstructured":"Ospina M, Wong L-Y, Baker SE, et al. Exposure to neonicotinoid insecticides in the U.S. general population: data from the 2015\u20132016 national health and nutrition examination survey. Environ Res. 2019;176:108555.","journal-title":"Environ Res"},{"key":"1016_CR6","doi-asserted-by":"publisher","first-page":"123728","DOI":"10.1016\/j.watres.2025.123728","volume":"282","author":"H Li","year":"2025","unstructured":"Li H, Xie L, Xu Z, et al. Advancing aquatic ecological risk assessment of imidacloprid in global surface water with mesocosm-based thresholds. Water Res. 2025;282:123728.","journal-title":"Water Res"},{"key":"1016_CR7","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/j.scitotenv.2019.03.040","volume":"669","author":"Y Tao","year":"2019","unstructured":"Tao Y, Phung D, Dong F, et al. Urinary monitoring of neonicotinoid imidacloprid exposure to pesticide applicators. Sci Total Environ. 2019;669:721\u201328.","journal-title":"Sci Total Environ"},{"key":"1016_CR8","doi-asserted-by":"publisher","first-page":"112703","DOI":"10.1016\/j.envres.2022.112703","volume":"208","author":"H Zhang","year":"2022","unstructured":"Zhang H, Zhang R, Zeng X, et al. Exposure to neonicotinoid insecticides and their characteristic metabolites: association with human liver cancer. Environ Res. 2022;208:112703.","journal-title":"Environ Res"},{"key":"1016_CR9","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.toxrep.2017.12.019","volume":"5","author":"S \u00d6zdemir","year":"2018","unstructured":"\u00d6zdemir S, Altun S, Arslan H. Imidacloprid exposure cause the histopathological changes, activation of TNF-\u03b1, iNOS, 8-OHdG biomarkers, and alteration of caspase 3, iNOS, CYP1A, MT1 gene expression levels in common carp (cyprinus carpio L.). Toxicol Rep. 2018;5:125\u201333.","journal-title":"Toxicol Rep"},{"key":"1016_CR10","doi-asserted-by":"publisher","first-page":"110600","DOI":"10.1007\/s11356-023-30187-3","volume":"30","author":"S Krief","year":"2023","unstructured":"Krief S, Spirhanzlova P, Masi S, et al. High urinary oxidative DNA damage in wild chimpanzees ranging in proximity of agricultural fields in sebitoli area, Uganda. Environ Sci Pollut Res Int. 2023;30:110600\u201311.","journal-title":"Environ Sci Pollut Res Int"},{"key":"1016_CR11","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1080\/10408444.2024.2310593","volume":"54","author":"I Benchikh","year":"2024","unstructured":"Benchikh I, Ziani K, Gonzalez Mateos A, et al. Non-acute exposure of neonicotinoids, health risk assessment, and evidence integration: a systematic review. Crit Rev Toxicol. 2024;54:194\u2013213.","journal-title":"Crit Rev Toxicol"},{"key":"1016_CR12","doi-asserted-by":"publisher","first-page":"175422","DOI":"10.1016\/j.scitotenv.2024.175422","volume":"951","author":"F Wei","year":"2024","unstructured":"Wei F, Cheng F, Li H, et al. Imidacloprid affects human cells through mitochondrial dysfunction and oxidative stress. Sci Total Environ. 2024;951:175422.","journal-title":"Sci Total Environ"},{"key":"1016_CR13","doi-asserted-by":"publisher","first-page":"130715","DOI":"10.1016\/j.jhazmat.2022.130715","volume":"446","author":"Y Chen","year":"2023","unstructured":"Chen Y, Yu W, Zhang L, et al. First evidence of neonicotinoid insecticides in human bile and associated hepatotoxicity risk. J Hazard Mater. 2023;446:130715.","journal-title":"J Hazard Mater"},{"key":"1016_CR14","doi-asserted-by":"publisher","first-page":"107568","DOI":"10.1016\/j.envint.2022.107568","volume":"170","author":"X Li","year":"2022","unstructured":"Li X, He S, Xiao H, et al. Neonicotinoid insecticides promote breast cancer progression via G protein-coupled estrogen receptor: in vivo, in vitro and in silico studies. Environ Int. 2022;170:107568.","journal-title":"Environ Int"},{"key":"1016_CR15","doi-asserted-by":"publisher","first-page":"047014","DOI":"10.1289\/EHP2698","volume":"126","author":"\u00c9 Caron-Beaudoin","year":"2018","unstructured":"Caron-Beaudoin \u00c9, Viau R, Sanderson JT. Effects of neonicotinoid pesticides on promoter-specific aromatase (CYP19) expression in Hs578t breast cancer cells and the role of the VEGF pathway. Environ Health Perspect. 2018;126:047014.","journal-title":"Environ Health Perspect"},{"key":"1016_CR16","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.eururo.2023.03.029","volume":"84","author":"I Jubber","year":"2023","unstructured":"Jubber I, Ong S, Bukavina L, et al. Epidemiology of bladder cancer in 2023: a systematic review of risk factors. Eur Urol. 2023;84:176\u201390.","journal-title":"Eur Urol"},{"key":"1016_CR17","doi-asserted-by":"publisher","first-page":"144948","DOI":"10.1016\/j.foodchem.2025.144948","volume":"489","author":"Y Chen","year":"2025","unstructured":"Chen Y, Kong D, Huang L, et al. Residue and metabolism of imidacloprid in cherry radish using a 14C study: implications for food safety. Food Chem: X. 2025;489:144948.","journal-title":"Food Chem: X"},{"key":"1016_CR18","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12929-023-00917-3","volume":"30","author":"C Wu","year":"2023","unstructured":"Wu C, Gong S, Duan Y, et al. A tumor microenvironment-based prognostic index for osteosarcoma. J Biomed Sci. 2023;30:23.","journal-title":"J Biomed Sci"},{"key":"1016_CR19","doi-asserted-by":"publisher","first-page":"28867","DOI":"10.1038\/s41598-024-79942-7","volume":"14","author":"Y Xiao","year":"2024","unstructured":"Xiao Y, Xu D, Bao E, et al. Identification of inflammation related gene signatures for bladder cancer prognosis prediction. Sci Rep. 2024;14:28867.","journal-title":"Sci Rep"},{"key":"1016_CR20","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1109\/TKDE.2008.239","volume":"21","author":"H He","year":"2009","unstructured":"He H, Garcia EA. Learning from imbalanced data. IEEE Trans Knowl Data Eng. 2009;21:1263\u201384.","journal-title":"IEEE Trans Knowl Data Eng"},{"key":"1016_CR21","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1186\/s12935-019-0950-7","volume":"19","author":"L Wang","year":"2019","unstructured":"Wang L, Shi J, Huang Y, et al. A six-gene prognostic model predicts overall survival in bladder cancer patients. Cancer Cell Int. 2019;19:229.","journal-title":"Cancer Cell Int"},{"key":"1016_CR22","doi-asserted-by":"publisher","first-page":"e2300661","DOI":"10.1200\/PO.23.00661","volume":"8","author":"I Safder","year":"2024","unstructured":"Safder I, Valentine H, Uzzo N, et al. Identification and validation of prognostic model for tumor microenvironment-associated genes in bladder cancer based on single-cell RNA sequencing data sets. JCO Precis Oncol. 2024;8:e2300661.","journal-title":"JCO Precis Oncol"},{"key":"1016_CR23","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1007\/s12672-024-01575-z","volume":"15","author":"D Song","year":"2024","unstructured":"Song D, Feng K, Luo W, et al. Predicting survival in bladder cancer with a novel apoptotic gene-related prognostic model. Discov Oncol. 2024;15:702.","journal-title":"Discov Oncol"},{"key":"1016_CR24","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s41065-025-00409-4","volume":"162","author":"H Dai","year":"2025","unstructured":"Dai H, Zhang X, Zhao Y, et al. ADME gene-driven prognostic model for bladder cancer: a breakthrough in predicting survival and personalized treatment. Hereditas. 2025;162:42.","journal-title":"Hereditas"},{"key":"1016_CR25","doi-asserted-by":"publisher","first-page":"1288699","DOI":"10.3389\/fimmu.2023.1288699","volume":"14","author":"Z Wang","year":"2023","unstructured":"Wang Z, Hu D, Pei G, et al. Identification of driver genes in lupus nephritis based on comprehensive bioinformatics and machine learning. Front Immunol. 2023;14:1288699.","journal-title":"Front Immunol"},{"key":"1016_CR26","doi-asserted-by":"publisher","first-page":"W159","DOI":"10.1093\/nar\/gkac394","volume":"50","author":"Y Liu","year":"2022","unstructured":"Liu Y, Yang X, Gan J, et al. CB-Dock2: improved protein-ligand blind docking by integrating cavity detection, docking and homologous template fitting. Nucleic Acids Res. 2022;50:W159\u201364.","journal-title":"Nucleic Acids Res"},{"key":"1016_CR27","doi-asserted-by":"publisher","first-page":"bbac087","DOI":"10.1093\/bib\/bbac087","volume":"23","author":"X Yang","year":"2022","unstructured":"Yang X, Liu Y, Gan J, et al. FitDock: protein-ligand docking by template fitting. Brief Bioinform. 2022;23:bbac087.","journal-title":"Brief Bioinform"},{"key":"1016_CR28","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s13321-019-0362-7","volume":"11","author":"EW Bell","year":"2019","unstructured":"Bell EW, Zhang Y. DockRMSD: an open-source tool for atom mapping and RMSD calculation of symmetric molecules through graph isomorphism. J Cheminform. 2019;11:40.","journal-title":"J Cheminform"},{"key":"1016_CR29","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1007\/s12672-025-02730-w","volume":"16","author":"H Xu","year":"2025","unstructured":"Xu H, Li J, Peng S, et al. From exposure to innovation: decoding aromatic amines\u2019 role in bladder cancer mechanisms. Discov Onc. 2025;16:888.","journal-title":"Discov Onc"},{"key":"1016_CR30","first-page":"10","volume":"1","author":"H Zhang","year":"2025","unstructured":"Zhang H, Zhang G, Xu P, et al. Optimized dynamic network biomarker deciphers a high-resolution heterogeneity within thyroid cancer molecular subtypes. Med Res. 2025;1:10\u201331.","journal-title":"Med Res"},{"key":"1016_CR31","doi-asserted-by":"publisher","first-page":"e18408","DOI":"10.1111\/jcmm.18408","volume":"28","author":"P Zhang","year":"2024","unstructured":"Zhang P, Yang Z, Liu Z, et al. Deciphering lung adenocarcinoma evolution: Integrative single-cell genomics identifies the prognostic lung progression associated signature. J Cell Mol Med. 2024;28:e18408.","journal-title":"J Cell Mol Med"},{"key":"1016_CR32","doi-asserted-by":"publisher","DOI":"10.1007\/s11010-025-05245-8","author":"A Caturano","year":"2025","unstructured":"Caturano A, Erul E, Nilo R, et al. Insulin resistance and cancer: molecular links and clinical perspectives. Mol Cell Biochem. Epub ahead of print 15 March 2025. https:\/\/doi.org\/10.1007\/s11010-025-05245-8.","journal-title":"Mol Cell Biochem"},{"key":"1016_CR33","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1124\/mol.60.1.80","volume":"60","author":"R Courjaret","year":"2001","unstructured":"Courjaret R, Lapied B. Complex intracellular messenger pathways regulate one type of neuronal alpha-bungarotoxin-resistant nicotinic acetylcholine receptors expressed in insect neurosecretory cells (dorsal unpaired median neurons). Mol Pharmacol. 2001;60:80\u201391.","journal-title":"Mol Pharmacol"},{"key":"1016_CR34","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.7150\/ijbs.69343","volume":"18","author":"J-C Huang","year":"2022","unstructured":"Huang J-C, Duan C-C, Jin S, et al. HB-EGF induces mitochondrial dysfunction via estrogen hypersecretion in granulosa cells dependent on cAMP-PKA-JNK\/ERK-Ca2\u00b1FOXO1 pathway. Int J Biol Sci. 2022;18:2047\u201359.","journal-title":"Int J Biol Sci"},{"key":"1016_CR35","doi-asserted-by":"publisher","first-page":"e012069","DOI":"10.1136\/jitc-2025-012069","volume":"13","author":"P Zhang","year":"2025","unstructured":"Zhang P, Zhang M, Liu J, et al. Mitochondrial pathway signature (MitoPS) predicts immunotherapy response and reveals NDUFB10 as a key immune regulator in lung adenocarcinoma. J Immunother Cancer. 2025;13:e012069.","journal-title":"J Immunother Cancer"},{"key":"1016_CR36","doi-asserted-by":"publisher","first-page":"118355","DOI":"10.1016\/j.jep.2024.118355","volume":"332","author":"Z Zhu","year":"2024","unstructured":"Zhu Z, Yu M, Xu M, et al. Baicalin suppresses macrophage JNK-mediated adipose tissue inflammation to mitigate insulin resistance in obesity. J Ethnopharmacol. 2024;332:118355.","journal-title":"J Ethnopharmacol"},{"key":"1016_CR37","doi-asserted-by":"publisher","first-page":"2611","DOI":"10.3390\/cancers13112611","volume":"13","author":"K Klein","year":"2021","unstructured":"Klein K, Stoiber D, Sexl V, et al. Untwining anti-tumor and immunosuppressive effects of JAK inhibitors-A strategy for hematological malignancies? Cancers (Basel). 2021;13:2611.","journal-title":"Cancers (Basel)"},{"key":"1016_CR38","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1186\/s12964-024-01575-0","volume":"22","author":"E McMullen","year":"2024","unstructured":"McMullen E, Strych L, Chodakova L, et al. JAK\/STAT mediated insulin resistance in muscles is essential for effective immune response. Cell Commun Signal. 2024;22:203.","journal-title":"Cell Commun Signal"},{"key":"1016_CR39","doi-asserted-by":"publisher","first-page":"200818","DOI":"10.1016\/j.omton.2024.200818","volume":"32","author":"M-A Papadimitriou","year":"2024","unstructured":"Papadimitriou M-A, Pilala K-M, Panoutsopoulou K, et al. CDKN2A copy number alteration in bladder cancer: integrative analysis in patient-derived xenografts and cancer patients. Mol Ther Oncol. 2024;32:200818.","journal-title":"Mol Ther Oncol"},{"key":"1016_CR40","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.eururo.2019.09.006","volume":"77","author":"A Kamoun","year":"2020","unstructured":"Kamoun A, de Reyni\u00e8s A, Allory Y, et al. A consensus molecular classification of muscle-invasive bladder cancer. Eur Urol. 2020;77:420\u201333.","journal-title":"Eur Urol"},{"key":"1016_CR41","first-page":"20701","volume":"8","author":"D Qi","year":"2015","unstructured":"Qi D, Li J, Jiang M, et al. The relationship between promoter methylation of p16 gene and bladder cancer risk: a meta-analysis. Int J Clin Exp Med. 2015;8:20701\u201311.","journal-title":"Int J Clin Exp Med"},{"key":"1016_CR42","doi-asserted-by":"crossref","unstructured":"Olkhov-Mitsel E, Oberc A, Craddock KJ, et al. MTAP protein status is highly concordant with CDKN2A fluorescent in situ hybridization and allows stratification of the luminal subtype in muscle-invasive bladder cancer. Histopathology. 2025;86:352\u201364.","DOI":"10.1111\/his.15324"},{"key":"1016_CR43","doi-asserted-by":"publisher","first-page":"2320","DOI":"10.1158\/2767-9764.CRC-24-0352","volume":"4","author":"NA Wijetunga","year":"2024","unstructured":"Wijetunga NA, Gessner KH, Kanchi K, et al. Poor prognosis among radiation-associated bladder cancer is defined by clinicogenomic features. Cancer Res Commun. 2024;4:2320\u201334.","journal-title":"Cancer Res Commun"},{"key":"1016_CR44","doi-asserted-by":"publisher","first-page":"4362","DOI":"10.1038\/s41467-021-24656-x","volume":"12","author":"L-Y Li","year":"2021","unstructured":"Li L-Y, Yang Q, Jiang Y-Y, et al. Interplay and cooperation between SREBF1 and master transcription factors regulate lipid metabolism and tumor-promoting pathways in squamous cancer. Nat Commun. 2021;12:4362.","journal-title":"Nat Commun"},{"key":"1016_CR45","doi-asserted-by":"publisher","first-page":"107199","DOI":"10.1016\/j.phrs.2024.107199","volume":"204","author":"Z Fu","year":"2024","unstructured":"Fu Z, Yuan Y. TNFAIP2 as an emerging therapeutic target in cancer therapy and its underlying mechanisms. Pharmacol Res. 2024;204:107199.","journal-title":"Pharmacol Res"},{"key":"1016_CR46","doi-asserted-by":"publisher","first-page":"5188","DOI":"10.1111\/jcmm.13822","volume":"22","author":"L Jia","year":"2018","unstructured":"Jia L, Shi Y, Wen Y, et al. The roles of TNFAIP2 in cancers and infectious diseases. J Cellular Mol Medi. 2018;22:5188\u201395.","journal-title":"J Cellular Mol Medi"},{"key":"1016_CR47","doi-asserted-by":"publisher","first-page":"114151","DOI":"10.1016\/j.yexcr.2024.114151","volume":"441","author":"Y Gui","year":"2024","unstructured":"Gui Y, Deng X, Li N, et al. PRELP reduce cell stiffness and adhesion to promote the growth and metastasis of colorectal cancer cells by binding to integrin \u03b15. Exp Cell Res. 2024;441:114151.","journal-title":"Exp Cell Res"},{"key":"1016_CR48","doi-asserted-by":"publisher","first-page":"3362","DOI":"10.3390\/cancers12113362","volume":"12","author":"V Papadaki","year":"2020","unstructured":"Papadaki V, Asada K, Watson JK, et al. Two secreted proteoglycans, activators of urothelial cell-cell adhesion, negatively contribute to bladder cancer initiation and progression. Cancers (Basel). 2020;12:3362.","journal-title":"Cancers (basel)"},{"key":"1016_CR49","doi-asserted-by":"publisher","first-page":"112180","DOI":"10.1016\/j.intimp.2024.112180","volume":"134","author":"H Huang","year":"2024","unstructured":"Huang H, Tang Q, Li S, et al. TGFBI: a novel therapeutic target for cancer. Int Immunopharmacol. 2024;134:112180.","journal-title":"Int Immunopharmacol"},{"key":"1016_CR50","doi-asserted-by":"publisher","first-page":"110028","DOI":"10.1016\/j.cellsig.2021.110028","volume":"84","author":"A Corona","year":"2021","unstructured":"Corona A, Blobe GC. The role of the extracellular matrix protein TGFBI in cancer. Cell Signal. 2021;84:110028.","journal-title":"Cell Signal"},{"key":"1016_CR51","doi-asserted-by":"publisher","first-page":"4483","DOI":"10.3390\/ijms20184483","volume":"20","author":"K Lang","year":"2019","unstructured":"Lang K, Kahveci S, Bonberg N, et al. TGFBI protein is increased in the urine of patients with high-grade urothelial carcinomas, and promotes cell proliferation and migration. Int J Mol Sci. 2019;20:4483.","journal-title":"Int J Mol Sci"},{"key":"1016_CR52","doi-asserted-by":"publisher","first-page":"e18135","DOI":"10.1371\/journal.pone.0018135","volume":"6","author":"A Zaravinos","year":"2011","unstructured":"Zaravinos A, Lambrou GI, Boulalas I, et al. Identification of common differentially expressed genes in urinary bladder cancer. PLoS One. 2011;6:e18135.","journal-title":"PLoS One"},{"key":"1016_CR53","doi-asserted-by":"publisher","first-page":"2935","DOI":"10.1021\/acschemneuro.0c00421","volume":"11","author":"W-W Zhang","year":"2020","unstructured":"Zhang W-W, Wang Y, Chu Y-X. Tacr3\/NK3R: Beyond their roles in reproduction. ACS Chem Neurosci. 2020;11:2935\u201343.","journal-title":"ACS Chem Neurosci"},{"key":"1016_CR54","doi-asserted-by":"publisher","first-page":"1472772","DOI":"10.3389\/fimmu.2024.1472772","volume":"15","author":"L Wang","year":"2024","unstructured":"Wang L, Zhang L, Zhang Z, et al. Advances in targeting tumor microenvironment for immunotherapy. Front Immunol. 2024;15:1472772.","journal-title":"Front Immunol"},{"key":"1016_CR55","first-page":"231","volume":"27","author":"Y Zhou","year":"2024","unstructured":"Zhou Y, Ren D, Bi H, et al. Tumor-associated macrophage: emerging targets for modulating the tumor microenvironment. Zhongguo Fei Ai Za Zhi. 2024;27:231\u201340.","journal-title":"Zhongguo Fei Ai Za Zhi"},{"key":"1016_CR56","doi-asserted-by":"publisher","first-page":"583084","DOI":"10.3389\/fimmu.2020.583084","volume":"11","author":"Y Pan","year":"2020","unstructured":"Pan Y, Yu Y, Wang X, et al. Tumor-associated macrophages in tumor immunity. Front Immunol. 2020;11:583084.","journal-title":"Front Immunol"},{"key":"1016_CR57","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/nrc.2016.2","volume":"16","author":"NP Restifo","year":"2016","unstructured":"Restifo NP, Smyth MJ, Snyder A. Acquired resistance to immunotherapy and future challenges. Nat Rev Cancer. 2016;16:121\u201326.","journal-title":"Nat Rev Cancer"},{"key":"1016_CR58","doi-asserted-by":"publisher","first-page":"616","DOI":"10.21147\/j.issn.1000-9604.2024.06.04","volume":"36","author":"Y Zhai","year":"2024","unstructured":"Zhai Y, Liang X, Deng M, et al. Myeloid cells meet CD8+ T cell exhaustion in cancer: what, why and how. Chin J Cancer Res. 2024;36:616\u201351.","journal-title":"Chin J Cancer Res"},{"key":"1016_CR59","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s13046-025-03377-9","volume":"44","author":"Y Yang","year":"2025","unstructured":"Yang Y, Li S, To KKW, et al. Tumor-associated macrophages remodel the suppressive tumor immune microenvironment and targeted therapy for immunotherapy. J Exp Clin Cancer Res. 2025;44:145.","journal-title":"J Exp Clin Cancer Res"},{"key":"1016_CR60","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s12943-023-01800-3","volume":"22","author":"X Chu","year":"2023","unstructured":"Chu X, Tian W, Wang Z, et al. Co-inhibition of TIGIT and PD-1\/PD-L1 in cancer immunotherapy: mechanisms and clinical trials. Mol Cancer. 2023;22:93.","journal-title":"Mol Cancer"},{"key":"1016_CR61","doi-asserted-by":"publisher","first-page":"101732","DOI":"10.1016\/j.toxrep.2024.101732","volume":"13","author":"A Mavadia","year":"2024","unstructured":"Mavadia A, Choi S, Ismail A, et al. An overview of immune checkpoint inhibitor toxicities in bladder cancer. Toxicol Rep. 2024;13:101732.","journal-title":"Toxicol Rep"},{"key":"1016_CR62","doi-asserted-by":"publisher","first-page":"6995","DOI":"10.3390\/ijms22136995","volume":"22","author":"AJ Boutilier","year":"2021","unstructured":"Boutilier AJ, Elsawa SF. Macrophage polarization states in the tumor microenvironment. Int J Mol Sci. 2021;22:6995.","journal-title":"Int J Mol Sci"},{"key":"1016_CR63","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1093\/intimm\/dxae042","volume":"37","author":"S Yamazaki","year":"2024","unstructured":"Yamazaki S. Diverse roles of dendritic cell and regulatory T cell crosstalk in controlling health and disease. Int Immunol. 2024;37:5\u201314.","journal-title":"Int Immunol"},{"key":"1016_CR64","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/s12943-025-02305-x","volume":"24","author":"M Zhang","year":"2025","unstructured":"Zhang M, Liu C, Tu J, et al. Advances in cancer immunotherapy: historical perspectives, current developments, and future directions. Mol Cancer. 2025;24:136.","journal-title":"Mol Cancer"},{"key":"1016_CR65","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/s42003-022-03369-x","volume":"5","author":"Y Zhou","year":"2022","unstructured":"Zhou Y, Takano T, Li X, et al. \u03b2-elemene regulates M1-M2 macrophage balance through the ERK\/JNK\/P38 MAPK signaling pathway. Commun Biol. 2022;5:519.","journal-title":"Commun Biol"}],"container-title":["BMC Pharmacology and Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40360-025-01016-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40360-025-01016-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40360-025-01016-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T07:03:16Z","timestamp":1764226996000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpharmacoltoxicol.biomedcentral.com\/articles\/10.1186\/s40360-025-01016-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,30]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1016"],"URL":"https:\/\/doi.org\/10.1186\/s40360-025-01016-9","relation":{},"ISSN":["2050-6511"],"issn-type":[{"value":"2050-6511","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,30]]},"assertion":[{"value":"13 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Informed consent for publication of the manuscript was obtained from all authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"180"}}